Siolta Therapeutics, Inc.
Vice President, Quality and CMC
Mary Poor is Vice President of Quality and CMC at Siolta Therapeutics, Inc. In this position, she oversees quality systems and GMP compliance to support Siolta's clinical pipeline. Prior to joining Siolta, she held positions in CMC regulatory compliance, quality assurance management, and research. She has broad experience in the biotechnology industry, including contract manufacturing, quality systems design and implementation, supplier management, live biotherapeutic products (LBPs), aseptic processing, development and provision of GxP training, and validation. Ms. Poor holds an M.S. in Microbiology from Colorado State University and has held professional certification in U.S. Regulatory Affairs from the Regulatory Affairs Professionals Society. She currently serves as member of the ISPE Rocky Mountain Chapter Board of Directors.